7Baggers

Phibro Animal Health Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 -8.0247.23102.47157.72212.96268.21323.45378.7Milllion

Phibro Animal Health Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2006-03-31 2005-12-31 2005-09-30 2005-06-30 
                                                 
  ​                                               
  net sales378,697,000 347,825,000 309,261,000 260,432,000 273,164,000 263,223,000 249,943,000 231,349,000 255,049,000 245,673,000 244,646,000 232,521,000 255,265,000 239,619,000 232,712,000 214,665,000 220,278,000 211,729,000 206,149,000 195,194,000 185,883,000 210,739,000 214,012,000 189,720,000 203,883,000 205,736,000 218,223,000 200,153,000 211,786,000 208,908,000 205,876,000  142,361,500 189,861,000 191,598,000 187,987,000        100,905,000 99,735,000 92,571,000  
  yoy38.63% 32.14% 23.73% 12.57% 7.10% 7.14% 2.17% -0.50% -0.08% 2.53% 5.13% 8.32% 15.88% 13.17% 12.89% 9.98% 18.50% 0.47% -3.67% 2.89% -8.83% 2.43% -1.93% -5.21% -3.73% -1.52% 6.00%  48.77% 10.03% 7.45%                 
  qoq8.88% 12.47% 18.75% -4.66% 3.78% 5.31% 8.04% -9.29% 3.82% 0.42% 5.21% -8.91% 6.53% 2.97% 8.41% -2.55% 4.04% 2.71% 5.61% 5.01% -11.79% -1.53% 12.80% -6.95% -0.90% -5.72% 9.03% -5.49% 1.38% 1.47%   -25.02% -0.91% 1.92%         1.17% 7.74%   
  cost of goods sold268,688,000 243,257,000 207,391,000 176,937,000 186,014,000 183,623,000 171,327,000 163,623,000 178,383,000 170,133,000 167,261,000 163,875,000 176,841,000 167,993,000 162,040,000 149,987,000 150,450,000 142,564,000 137,884,000 131,075,000 125,319,000 141,188,000 144,908,000 132,057,000 138,580,000 140,864,000 149,579,000 134,348,000 144,277,000 139,839,000 138,957,000  96,082,250 129,241,000 128,100,000 126,988,000        76,442,000 79,490,000 73,411,000  
  gross profit110,009,000 104,568,000 101,870,000 83,495,000 87,150,000 79,600,000 78,616,000 67,726,000 76,666,000 75,540,000 77,385,000 68,646,000 78,424,000 71,626,000 70,672,000 64,678,000 69,828,000 69,165,000 68,265,000 64,119,000 60,564,000 69,551,000 69,104,000 57,663,000 65,303,000 64,872,000 68,644,000 65,805,000 67,509,000 69,069,000 66,919,000  46,279,250 60,620,000 63,498,000 60,999,000        24,463,000 20,245,000 19,160,000  
  yoy26.23% 31.37% 29.58% 23.28% 13.67% 5.37% 1.59% -1.34% -2.24% 5.46% 9.50% 6.14% 12.31% 3.56% 3.53% 0.87% 15.30% -0.55% -1.21% 11.20% -7.26% 7.21% 0.67% -12.37% -3.27% -6.08% 2.58%  45.87% 13.94% 5.39%                 
  qoq5.20% 2.65% 22.01% -4.19% 9.48% 1.25% 16.08% -11.66% 1.49% -2.38% 12.73% -12.47% 9.49% 1.35% 9.27% -7.38% 0.96% 1.32% 6.47% 5.87% -12.92% 0.65% 19.84% -11.70% 0.66% -5.50% 4.31% -2.52% -2.26% 3.21%   -23.66% -4.53% 4.10%         20.83% 5.66%   
  gross margin %29.05% 30.06% 32.94% 32.06% 31.90% 30.24% 31.45% 29.27% 30.06% 30.75% 31.63% 29.52% 30.72% 29.89% 30.37% 30.13% 31.70% 32.67% 33.11% 32.85% 32.58% 33.00% 32.29% 30.39% 32.03% 31.53% 31.46% 32.88% 31.88% 33.06% 32.50%  32.51% 31.93% 33.14% 32.45%        24.24% 20.30% 20.70%  
  selling, general and administrative expenses76,291,000 71,053,000 76,337,000 65,796,000 68,734,000 59,676,000 62,915,000 68,452,000 52,900,000 56,987,000 61,541,000 54,962,000 55,538,000 52,432,000 48,378,000 50,066,000 50,670,000 49,033,000 48,375,000 48,431,000 42,445,000 48,232,000 49,495,000 47,516,000 53,204,000 42,304,000 42,938,000 42,952,000 41,400,000 42,577,000 42,981,000  27,675,500 30,646,000 40,870,000 39,186,000        17,527,000 16,780,000 15,065,000  
  operating income33,718,000 33,515,000 25,533,000 17,699,000 18,416,000 19,924,000 15,701,000 -726,000 23,766,000 18,553,000 15,844,000 13,684,000 22,886,000 19,194,000 22,294,000 14,612,000 19,158,000 20,132,000 19,890,000 15,688,000 18,119,000 21,319,000 19,609,000 10,147,000 12,099,000 22,568,000 25,706,000 22,853,000 26,109,000 26,492,000 23,938,000  18,603,750 29,974,000 22,628,000 21,813,000        6,936,000 3,465,000 4,095,000  
  yoy83.09% 68.21% 62.62% -2537.88% -22.51% 7.39% -0.90% -105.31% 3.85% -3.34% -28.93% -6.35% 19.46% -4.66% 12.09% -6.86% 5.73% -5.57% 1.43% 54.61% 49.76% -5.53% -23.72% -55.60% -53.66% -14.81% 7.39%  40.34% -11.62% 5.79%                 
  qoq0.61% 31.26% 44.26% -3.89% -7.57% 26.90% -2262.67% -103.05% 28.10% 17.10% 15.78% -40.21% 19.24% -13.91% 52.57% -23.73% -4.84% 1.22% 26.78% -13.42% -15.01% 8.72% 93.25% -16.13% -46.39% -12.21% 12.48% -12.47% -1.45% 10.67%   -37.93% 32.46% 3.74%         100.17% -15.38%   
  operating margin %8.90% 9.64% 8.26% 6.80% 6.74% 7.57% 6.28% -0.31% 9.32% 7.55% 6.48% 5.89% 8.97% 8.01% 9.58% 6.81% 8.70% 9.51% 9.65% 8.04% 9.75% 10.12% 9.16% 5.35% 5.93% 10.97% 11.78% 11.42% 12.33% 12.68% 11.63%  13.07% 15.79% 11.81% 11.60%        6.87% 3.47% 4.42%  
  interest expense8,610,000 9,355,000 8,996,000 7,641,000 4,738,000 4,575,000 4,659,000 4,564,000 4,499,000 3,871,000 3,884,000 3,067,000 3,108,000 2,925,000 2,953,000 2,889,000 3,923,000 2,933,000 3,214,000 2,810,000 2,807,000 3,263,000 3,432,000 3,354,000 3,047,000 2,931,000 3,015,000 2,783,000 2,678,000 3,064,000 3,050,000  2,927,000 3,929,000 3,872,000 3,907,000        6,726,000 5,866,000 6,591,000  
  foreign currency (gains) losses1,652,250 -5,528,000       -2,174,000 -422,000 -149,000    -4,189,000 2,128,000 -890,000 -583,000 624,000 -3,631,000 -1,069,000 -608,000 -718,000 3,221,000 -159,000 122,000 2,617,000 -2,635,000 -96,000 -960,000 -323,000  -154,250 -403,000 -548,000 334,000            
  income before income taxes23,847,000 29,688,000 4,838,000 9,620,000 6,408,000 12,922,000 3,565,000 -11,979,000 21,441,000 15,104,000 12,109,000 5,417,000 12,369,000 26,833,000 23,530,000 9,595,000 16,125,000 17,782,000 16,052,000 16,509,000 16,381,000 18,664,000 16,895,000 3,572,000 9,211,000 19,515,000 20,074,000 22,705,000 23,527,000 24,388,000 21,211,000  15,831,000 26,448,000 19,304,000 17,572,000            
  benefit from income taxes6,623,000 8,808,000   5,656,000 4,517,000   9,943,000 5,062,000 4,899,000 1,561,000 4,882,000 9,144,000 6,065,000 3,061,000 -996,000 5,621,000 3,251,000 4,207,000 10,739,000 5,163,000 5,001,000 1,057,000 409,000 4,666,000 5,326,000 6,391,000        5,395,000        1,591,000  1,058,000  
  net income17,224,000 20,880,000 3,185,000 6,975,000 752,000 8,405,000 1,274,000 -8,015,000 11,498,000 10,042,000 7,210,000 3,856,000 7,487,000 17,689,000 17,465,000 6,534,000 17,121,000 12,161,000 12,801,000 12,302,000 5,642,000 13,501,000 11,894,000 2,515,000 8,802,000 14,849,000 14,748,000 16,314,000 22,119,000 19,840,000 7,032,000  12,309,250 23,643,000 13,417,000 12,177,000            
  yoy2190.43% 148.42% 150.00% -187.02% -93.46% -16.30% -82.33% -307.86% 53.57% -43.23% -58.72% -40.99% -56.27% 45.46% 36.43% -46.89% 203.46% -9.93% 7.63% 389.15% -35.90% -9.08% -19.35% -84.58% -60.21% -25.16% 109.73%  79.69% -16.09% -47.59%                 
  qoq-17.51% 555.57% -54.34% 827.53% -91.05% 559.73% -115.90% -169.71% 14.50% 39.28% 86.98% -48.50% -57.67% 1.28% 167.29% -61.84% 40.79% -5.00% 4.06% 118.04% -58.21% 13.51% 372.92% -71.43% -40.72% 0.68% -9.60% -26.24% 11.49% 182.14%   -47.94% 76.22% 10.18%             
  net income margin %4.55% 6.00% 1.03% 2.68% 0.28% 3.19% 0.51% -3.46% 4.51% 4.09% 2.95% 1.66% 2.93% 7.38% 7.50% 3.04% 7.77% 5.74% 6.21% 6.30% 3.04% 6.41% 5.56% 1.33% 4.32% 7.22% 6.76% 8.15% 10.44% 9.50% 3.42%  8.65% 12.45% 7.00% 6.48%        0% 0% 0%  
  net income per share                                               
  basic0.42 0.52 0.08 0.17 0.02 0.21 0.03 -0.2     0.18 0.44 0.43 0.16 0.42 0.3 0.32 0.3 0.14 0.33 0.29 0.06 0.21 0.37 0.37 0.4 0.54 0.49 0.17  0.313 0.6 0.34 0.31            
  diluted0.43 0.51 0.08 0.17 0.02 0.21 0.03 -0.2     0.18 0.44 0.43 0.16 0.42 0.3 0.32 0.3 0.14 0.33 0.29 0.06 0.22 0.37 0.36 0.4 0.55 0.49 0.17  0.308 0.59 0.34 0.31            
  weighted-average common shares outstanding                                               
  basic40,515 40,520 40,504 40,504 40,504 40,504 40,504 40,504 40,504    40,504 40,504 40,504 40,504 40,473 40,483 40,454 40,454 40,454 40,454 40,454 40,454 40,412 40,442 40,383 40,369 40,181 40,254 40,186   39,512 39,411 39,408            
  diluted40,678 40,709 40,715 40,582 40,523 40,520 40,504 40,504 40,504    40,504 40,504 40,504 40,504 40,504 40,504 40,504 40,504 40,504 40,504 40,504 40,504 40,523 40,531 40,523 40,560 40,385 40,390 40,364   40,059 40,002 39,906            
  foreign currency losses  11,699,000 438,000    6,689,000    5,200,000                                    
  benefit for income taxes  1,653,000 2,645,000   2,291,000 -3,964,000                     1,408,000 4,548,000 14,179,000  3,521,750 2,805,000 5,887,000          1,649,000   
  foreign currency losses (gains)    4,148,250 2,427,000 7,477,000                                         
  net income per share                                               
  basic and diluted        0.13 0.25 0.18 0.1                                    
  weighted-average common shares outstanding                                               
  basic and diluted         40,504 40,504 40,504                                    
  foreign currency (gains)            -3,156,250 -10,564,000                                  
  dividends per share                           0.1 0.1 0.1 0.1  0.075 0.1 0.1 0.1            
  weighted-average common shares outstanding:                                               
  basic40,515 40,520 40,504 40,504 40,504 40,504 40,504 40,504 40,504    40,504 40,504 40,504 40,504 40,473 40,483 40,454 40,454 40,454 40,454 40,454 40,454 40,412 40,442 40,383 40,369 40,181 40,254 40,186   39,512 39,411 39,408            
  diluted40,678 40,709 40,715 40,582 40,523 40,520 40,504 40,504 40,504    40,504 40,504 40,504 40,504 40,504 40,504 40,504 40,504 40,504 40,504 40,504 40,504 40,523 40,531 40,523 40,560 40,385 40,390 40,364   40,059 40,002 39,906            
  interest expense, stockholders                                               
  interest                                           -53,000 -116,000 -90,000  
  other income                                           31,000 -1,919,000 -673,000  
  income from continuing operations before income taxes                                           232,000  -1,733,000  
  (loss) from continuing operations                                           -1,359,000 -2,015,000 -2,791,000  
  income from discontinued operations, net of income taxes                                               
  net                                           -1,359,000 -2,015,000 -2,791,000  
  other comprehensive income:                                               
  change in derivative instruments, net of income taxes                                           76,000 -220,000 100,000  
  change in foreign currency translation adjustment, net of income taxes                                           2,482,000  2,040,000  
  comprehensive income                                           1,199,000 -4,489,000 -651,000  
  excess of the reduction of series b and c preferred stock over total assets divested and costs and liabilities incurred on the prince transactions                                               
  dividends and equity value adjustment on series c preferred stock                                               
  net (loss) attributable to common stockholders                                           -1,359,000 -2,015,000 -2,791,000  
  other:                                               
  (loss) from continuing operations before income taxes                                            -366,000   
  discontinued operations:                                               
  change in foreign currency translation adjustment                                            -2,254,000   
  dividends and equity value accreted on series c preferred stock                                               

We provide you with 20 years income statements for Phibro Animal Health stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Phibro Animal Health stock. Explore the full financial landscape of Phibro Animal Health stock with our expertly curated income statements.

The information provided in this report about Phibro Animal Health stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.